American Journal of Obstetrics & Gynecology
Volume 190, Issue 6 , Pages 1654-1660 , June 2004

The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis

References 

  1. Knochenhaur ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078–3082
  2. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774–800
  3. Nestler JE, Jakubowicz DJ, Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1999;83:2001–2005
  4. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, et al.  A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1991;72:83–89
  5. Ek I, Arner P, Bergqvist A, Carlstrom K, Wahrenberg H. Impaired adipocytes lipolysis in nonobese women with polycystic ovary syndrome: a possible link to insulin resistance?. J Clin Endocrinol Metab. 1997;82:1147–1153
  6. Arner P. Control of lipolysis and its relevance to development of obesity in man. Diabetes Metab Rev. 1988;4:507–515
  7. Barbieri RL, Ryan KJ. Hyperandrogenism, insulin resistance and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features. Am J Obstet Gynecol. 1983;147:90–101
  8. Nestler JE, Stovall D, Akhter N, Iuorno MJ, Jakubowicz DJ. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril. 2001;77:209–215
  9. Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril. 2002;77:1095–1105
  10. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med. 1998;338:1876–1880
  11. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, et al.  Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab. 2000;85:139–146
  12. Legro RS, Finegood D, Duanif A. A fasting glucose to insulin ratio is a useful measure of insulin sensistivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998;83:2964–2968
  13. Ciaraldi TP, El-roeiy A, Madar Z, Reichert D, Olefsky JM, Yen SS. Cellular mechanism of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab. 1992;75:577–583
  14. Dunaif A, Xia J, Book C, Schenker E, Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: a potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest. 1995;96:801–810
  15. Grigorescu F, White MF, Kahn CR. Insulin binding and insulin-dependent phosphorylation of the insulin receptor solubilized from human erythrocytes. J Biol Chem. 1983;258:13708–13716
  16. Suzuki S, Toyota T, Goto Y. Characterization of the insulin receptor kinase from erythrocytes. Endocrinology. 1987;121:972–979
  17. Hagino H, Shii K, Yokono K, Matsuba H, Yoshida M, Hosomi Y, et al.  Enzyme-linked immunosorbent assay method for human autophosphorylated insulin receptor. Diabetes. 1994;43:274–280
  18. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440–1447
  19. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38:1163–1174
  20. Chang RJ, Nakamura RM, Judd HL, Kaplan SA. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 1983;57:356–359
  21. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. J Clin Invest. 1997;100:1166–1173
  22. Holte J, Bergh T, Berne C, Berglund L, Lithell H. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab. 1994;78:1052–1058
  23. Veldhuis JD, Furlanetta RW. Tropic actions of human somatomedin C-insulin-like growth factor I on ovarian cells: in vitro studies with swine granulosa cells. Endocrinology. 1985;116:1235–1242
  24. Barbieri RL, Smith S, Ryan KJ. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril. 1988;50:197–212
  25. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 1986;62:904–910
  26. Bergh C, Carlsson B, Olsson JH, Selleskog U, Hillensjo T. Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil Steril. 1993;59:323–331
  27. Adashi EY, Hsueh AJW, Yen SSC. Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology. 1981;108:1441–1449
  28. Rodriguez M, Arias P, Refojo D, Feleder C, Moguilevsky J. Arrest of pulsatile luteinizing hormone secretion during insulin-induced hypoglycemia: improvement by intrahypothalamic perfusion with glucose. Exp Clin Endocrinol Diabetes. 1999;107:257–261
  29. Murakawa H, Hasegawa I, Kurabayashi T, Tanaka K. Polycystic ovary syndrome. Insulin resistance and ovulatory responses to clomiphene citrate. J Reprod Med. 1999;44:23–27
  30. Kasuga M, Hedo JA, Yamada KM, Kahn CR. The structure of the insulin receptor and its subunits: evidence for multiple-non-reduced forms and a 210 kD possible proreceptor. J Biol Chem. 1982;257:10392–10399
  31. Kasuga M, Karlsson FA, Kahn CR. Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science. 1982;215:185–187

☆ Presented at the Seventieth Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, September 16-21, 2003, Anchorage, Alaska.

PII: S0002-9378(04)00215-7

doi: 10.1016/j.ajog.2004.02.052

American Journal of Obstetrics & Gynecology
Volume 190, Issue 6 , Pages 1654-1660 , June 2004

Article Tools

* Image Usage & Resolution